Mata Uang Fiat
Mata Uang Kripto
Tidak ada hasil untuk ""
Kami tidak dapat menemukan apa pun yang cocok dengan pencarian Anda. Coba lagi dengan istilah yang berbeda.
NewLimit - Series A
Ikhtisar
Tanggal Pendanaan
May 16, 2023
Jumlah Pendanaan
$40M
Valuasi Pendanaan
--
Kategori
Subkategori
--
Tentang NewLimit - Series A
Investor
Investor | Tipe | Lokasi | Tahun Didirikan | #Perusahaan Portofolio | Alamat Email | Sosial |
---|---|---|---|---|---|---|
Fund | United States of America | -- | 1 | -- | ||
Fund | United States of America | 1972 | 15 | [email protected] | ||
Fund | United States of America | 2005 | 36 | [email protected] | ||
Angel Investor | -- | -- | 2 | -- | ||
Angel Investor | United States of America | -- | 7 | -- |
Pendiri
Brian Armstrong
Greg Johnson
Jacob Kimmel
Profil Perusahaan / Pengenalan Proyek
NewLimit was founded to cure aging. They are working toward this goal by uncovering sets of transcription factors that can epigenetically reprogram cells. Although its products are designed to treat aging itself, NewLimit also believe these products could treat or prevent many diseases associated with aging, including fibrosis, infectious disease, and neurodegenerative disease.